TYROSINE PHOSPHORYLATION OF CD19 IN PRE-B-CELLS AND MATURE B-CELLS

被引:79
作者
CHALUPNY, NJ
KANNER, SB
SCHIEVEN, GL
WEE, SF
GILLILAND, LK
ARUFFO, A
LEDBETTER, JA
机构
[1] The Bristol-Myers Squibb, Pharmaceutical Research Institute, Seattle, WA 98121
关键词
ACTIVATION; SH2; DOMAIN; SIGNALING;
D O I
10.1002/j.1460-2075.1993.tb05930.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cross-linking of B cell surface immunoglobulins (sIg) results in activation of mature B cells and stimulates a molecular signaling mechanism for antigen-specific B cell expansion and differentiation. This signaling pathway is dependent on tyrosine (Tyr) phosphorylation and results in the activation of sIg-associated src family kinases and p72SYK. Rapid Tyr phosphorylation occurs on multiple protein substrates. Here we show that activation of B cells by cross-linking sIg results in an increase in Tyr phosphorylation of the lineage-restricted B cell surface antigen CD19, and show that it is a major substrate of activated Tyr kinase following sIg stimulation. Lower levels of constitutive CD19 Tyr phosphorylation occurred in most sIg+ mature B cell lines examined and in normal dense tonsillar B cells. We also rind that when CD19 is Tyr-phosphorylated it becomes competent to interact with SH2 domains suggesting a mechanism whereby, following B cell activation, CD19 could be linked to intracellular signaling pathways. In sIg- pre-B cell lines, CD19 was expressed but was not constitutively phosphorylated on tyrosine. Upon CD19 cross-linking, Tyr phosphorylation of CD19 was induced in sIg- pre-B cell lines. CD19 cross-linking also directly induced Tyr phosphorylation of CD19 and other substrates in mature B cells. The ability of CD19 to signal in the absence of sIg expression may provide important stimulation in pre-B cell development.
引用
收藏
页码:2691 / 2696
页数:6
相关论文
共 50 条
[31]   A critical role for the protein kinase PKK in the maintenance of recirculating mature B cells and the development of B1 cells [J].
Chen, Luojing ;
Oleksyn, David ;
Pulvino, Mary ;
Sanz, Ignacio ;
Ryan, Daniel ;
Ryan, Charlotte ;
Lin, Chyuan-sheng ;
Poligone, Brian ;
Pentland, Alice P. ;
Ritchlin, Christopher ;
Zhao, Jiyong .
IMMUNOLOGY LETTERS, 2016, 172 :67-78
[32]   Calmodulin inhibition of E2A stops expression of surrogate light chains of the pre-B-cell receptor and CD19 [J].
Hauser, Jannek ;
Wallenius, Anders ;
Sveshnikova, Natalia ;
Saarikettu, Juha ;
Grundstrom, Thomas .
MOLECULAR IMMUNOLOGY, 2010, 47 (05) :1031-1038
[33]   BCR mediated signal transduction in immature and mature B cells [J].
Koncz, G ;
Bodor, C ;
Kövesdi, D ;
Gáti, R ;
Sármay, G .
IMMUNOLOGY LETTERS, 2002, 82 (1-2) :41-49
[34]   Requirement for Rictor in homeostasis and function of mature B lymphoid cells [J].
Lee, Keunwook ;
Heffington, Lindsey ;
Jellusova, Julia ;
Nam, Ki Taek ;
Raybuck, Ariel ;
Cho, Sung Hoon ;
Thomas, James W. ;
Rickert, Robert C. ;
Boothby, Mark .
BLOOD, 2013, 122 (14) :2369-2379
[35]   A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19+ tumor cells [J].
Reusch, Uwe ;
Duell, Johannes ;
Ellwanger, Kristina ;
Herbrecht, Carmen ;
Knackmuss, Stefan H. J. ;
Fucek, Ivica ;
Eser, Markus ;
McAleese, Fionnuala ;
Molkenthin, Vera ;
Le Gall, Fabrice ;
Topp, Max ;
Little, Melvyn ;
Zhukovsky, Eugene A. .
MABS, 2015, 7 (03) :584-604
[36]   CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1- Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells [J].
Tao, Lei ;
Farooq, Muhammad Asad ;
Gao, Yaoxin ;
Zhang, Li ;
Niu, Congyi ;
Ajmal, Iqra ;
Zhou, Ying ;
He, Cong ;
Zhao, Guixia ;
Yao, Jie ;
Liu, Mingyao ;
Jiang, Wenzheng .
CANCERS, 2020, 12 (09) :1-17
[37]   Early and late hematologic toxicity following CD19 CAR-T cells [J].
Fried, Shalev ;
Avigdor, Abraham ;
Bielorai, Bella ;
Meir, Amilia ;
Besser, Michal J. ;
Schachter, Jacob ;
Shimoni, Avichai ;
Nagler, Arnon ;
Toren, Amos ;
Jacoby, Elad .
BONE MARROW TRANSPLANTATION, 2019, 54 (10) :1643-1650
[38]   CD19 Chimeric Antigen Receptor Therapy for Refractory Aggressive B-Cell Lymphoma [J].
Jacobson, Caron A. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04) :328-+
[39]   Production and characterization of haploidentical CD19 CAR T cells: Validated to induce a continuous complete remission in a patient with relapsed refractory B-cell ALL [J].
Prasongtanakij, Somsak ;
Anurathapan, Usanarat ;
Vanichapol, Thitinee ;
Jittorntrum, Bunyada ;
Atjanasuppat, Korakot ;
Pongpitcha, Pongpak ;
Pakakasama, Samart ;
Songdej, Duantida ;
Sirachainan, Nongnuch ;
Paisooksantivatana, Karan ;
Borwaornpinyo, Suparerk ;
Andersson, Borje S. ;
Hongeng, Suradej .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (01) :44-51
[40]   A Recombinant Bispecific CD20 x CD95 Antibody With Superior Activity Against Normal and Malignant B-cells [J].
Nalivaiko, Kristina ;
Hofmann, Martin ;
Kober, Karina ;
Teichweyde, Nadine ;
Krammer, Peter H. ;
Rammensee, Hans-Georg ;
Grosse-Hovest, Ludger ;
Jung, Gundram .
MOLECULAR THERAPY, 2016, 24 (02) :298-305